RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,049 | +126.6% | 971,441 | +170.9% | 0.09% | +95.7% |
| Q2 2023 | $463 | +8.2% | 358,626 | +10.6% | 0.05% | +9.5% |
| Q1 2023 | $428 | +199.3% | 324,398 | +240.5% | 0.04% | +133.3% |
| Q4 2022 | $143 | -100.0% | 95,269 | -17.2% | 0.02% | -58.1% |
| Q3 2021 | $418,000 | +660.0% | 115,036 | +617.0% | 0.04% | +377.8% |
| Q1 2021 | $55,000 | -64.5% | 16,043 | -81.0% | 0.01% | -89.5% |
| Q2 2020 | $155,000 | -56.0% | 84,429 | -62.6% | 0.09% | -2.3% |
| Q1 2020 | $352,000 | -33.0% | 225,547 | -8.1% | 0.09% | +44.3% |
| Q4 2019 | $525,000 | +39.6% | 245,487 | +22.1% | 0.06% | +19.6% |
| Q3 2019 | $376,000 | +317.8% | 201,128 | +620.9% | 0.05% | +920.0% |
| Q3 2018 | $90,000 | +73.1% | 27,900 | +110.1% | 0.01% | +25.0% |
| Q1 2014 | $52,000 | – | 13,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,847,087 | $4,119,000 | 3.26% |
| Sio Capital Management, LLC | 1,333,696 | $2,974,000 | 1.52% |
| Boxer Capital, LLC | 700,000 | $1,561,000 | 1.38% |
| Palo Alto Investors LP | 5,386,534 | $12,012,000 | 0.91% |
| ACUTA CAPITAL PARTNERS, LLC | 747,748 | $1,667,000 | 0.80% |
| SENZAR ASSET MANAGEMENT, LLC | 1,443,003 | $3,217,897,000 | 0.70% |
| Ghost Tree Capital, LLC | 800,000 | $1,784,000 | 0.52% |
| NEA Management Company, LLC | 3,243,150 | $7,232,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 850,000 | $1,896,000 | 0.34% |
| Rock Springs Capital Management LP | 1,750,000 | $3,903,000 | 0.29% |